Early prenatal exposure to immunosuppressive drugs not linked to harm

11/3/2013 | MedPage Today (free registration)

Taking immunosuppressive drugs to treat autoimmune diseases during the first trimester of pregnancy was not associated with significantly higher rates of adverse fetal events such as congenital malformations and fetal death, according to a U.S. study published in the journal Arthritis & Rheumatism.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care